Infección por hepatitis C: Enfoque para dermatólogos

  • Ximena Hormaza Universidad del Valle
Palabras clave: hepatitis C, manifestaciones cutáneas por virus de la hepatitis C

Resumen

La infección por el virus de la hepatitis C (VHC) es una epidemia mundial importante, causada por un virus RNA que produce tres tipos de péptidos que lo conforman y garantizan su variabilidad. La forma principal de adquisición es a través del uso de drogas endovenosas ilícitas. Sus manifestaciones son hepáticas y extrahepáticas. Las cutáneas hacen parte de las extrahepáticas y, aunque frecuentes, son poco detectadas. Estas señales de infección por el VHC se pueden clasificar en asociaciones demostradas, asociaciones probables, asociaciones con casos esporádicos, y asociación con el tratamiento para VHC.

Biografía del autor/a

Ximena Hormaza, Universidad del Valle

RII Dermatología Universidad del Valle.

Referencias bibliográficas

Beeson PB. Jaundice occurring one to four months after transfusion of blood or plasma: report of 7 cases. JAMA 1943; 21:1332.

https://doi.org/10.1001/jama.1943.02840170016005

Krugman S. lnfectious diseases of children. Mosby 1998:157-188.

Bonkovsky H, Mehta S. Hepatitis C: a review and update.J Am Acad Dermatol 2001;44:159-179.

https://doi.org/10.1067/mjd.2001.109311

Krugman S, Giles JP, Hammond J. Infectious hepatitis: evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA 1967; 200:365-373.

https://doi.org/10.1001/jama.1967.03120180053006

Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-362.

https://doi.org/10.1126/science.2523562

Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecie and genotypes. Semin Liver Dis 1995; 15:41-63.

https://doi.org/10.1055/s-2007-1007262

Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19:1321-1324.

https://doi.org/10.1002/hep.1840190538

Wu YY, Hsu TC, Chen TY, et al. Proteinase and dihydrolipoamide dehydrogenasa (E3) are major autoantigens in hepatitis C virus infection. Clin Exp Immunol 2002; 128:347-352.

https://doi.org/10.1046/j.1365-2249.2002.01827.x

Clifford BD ,Donahue D , Smith L , e t al. High prevalence of serologic markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21:613-619.

https://doi.org/10.1002/hep.1840210302

Lauer GM, Walker BD. Hepatitis C infection. N Engl J Med 2001; 345:41-52.

https://doi.org/10.1056/NEJM200107053450107

Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-562.

https://doi.org/10.1056/NEJM199908193410802

Echavarría E. Estudio de anticuerpos contra el virus de la hepatitis C en donantes y grupos de alto riesgo. Acta Med Colomb 1991; 17:11-15.

Buelvas AC, Mena M, López A.Prevalencia de anticuerpos contra el virus de la hepatitis C en donantes voluntarios de sangre. Colombia Med 1992; 23:21-23.

Hoyos A, Vanegas N, Páez E. Epidemiología de la hepatitis C en Colombia. Acta Med Colomb 2002; 27:209- 217.

Schreiber GB,Busch MP,Kleinman SH,et al.Therisk of transfusion-transmitted viral infections. N Engl J Med 1996; 334:1685-1690.

https://doi.org/10.1056/NEJM199606273342601

Legler TJ, Riggert J, Simson G, et al. Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection. Transfusion 2000; 40:1192-1197.

https://doi.org/10.1046/j.1537-2995.2000.40101192.x

Katsoulidou A, Paraskevis D, Kalapothaki V, et al. Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit: Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant 1999; 14:1188-1194.

https://doi.org/10.1093/ndt/14.5.1188

Bronowicki JP,Venard V,Botte C,et al.Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997; 337:237-240.

https://doi.org/10.1056/NEJM199707243370404

Esteban JI, Gómez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996; 334:555-558.

https://doi.org/10.1056/NEJM199602293340902

Thomas DL, Factor SH, Kelen GD, et al.Viral hepatitis in health care personnel at The Johns Hopkins Hospital: the seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med 1993; 153:1705-1712.

https://doi.org/10.1001/archinte.1993.00410140095011

Mitsui T, Iwano K, Masuko K, et al. Hepatitis C virus infection in medical personnel after needle-stick accident. Hepatology 1992; 16:1109-1114.

https://doi.org/10.1002/hep.1840160502

Ross RS, Viazov S, Gross T, et al. Transmission of hepatitis C virus from a patient to an anesthesiology assistant to five patients. N Engl J Med 2000; 343:1851-1854.

https://doi.org/10.1056/NEJM200012213432505

Eyster ME, Alter HJ, Aledort LM, et al. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med 1991; 115:764-768.

https://doi.org/10.7326/0003-4819-115-10-764

Ohto H. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994; 330:744-750.

https://doi.org/10.1056/NEJM199403173301103

Roudot TF. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6.664 patients. Hepatol 1997; 26:485-490.

https://doi.org/10.1002/hep.510260233

Amovoso P, Rapicetta M, Tosti ME, et al. Correlation between virus genotype and chronicity rate in acute hepatitis C. J Hepatol 1998; 28:939-944.

https://doi.org/10.1016/S0168-8278(98)80340-1

Villano SA, Vlahov D, Nelson KE, et al. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999; 29:908-914.

https://doi.org/10.1002/hep.510290311

Viguier M. B-cell lynphomas involving the skin associ- ated with hepatitis C virus infection. lnt J Dermatol 2002; 41:577-582.

https://doi.org/10.1046/j.1365-4362.2002.01603.x

Agnello V. The etiology and pathophysiology of mixed cryo-globulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997; 19:111-129.

https://doi.org/10.1007/BF00945029

Levey JM, Bjornsson B, Banner B, et al. Mixed cryoglobulinemia in chronic hepatitis C infection: a clinicopathologic analysis of 1O cases and review of recent literature. Medicine 1994; 73:53-67.

https://doi.org/10.1097/00005792-199401000-00005

Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327:1490-1495.

https://doi.org/10.1056/NEJM199211193272104

Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 1998; 27:1661-1669.

https://doi.org/10.1002/hep.510270627

Lazaro P, Olalquiaga J, Bartolome J. Detection of hepatitis C virus RNA and core protein in keratinocytes from patients with cutaneous lichen planus and chronic hepatitis C. J Invest Dermatol 2002; 119:798-803.

https://doi.org/10.1046/j.1523-1747.2002.00609.x

Olalquiaga J, Hernández I, Sendino R, et al. Infección por virus de la hepatitis C asociada a liquen plano. Estudio epidemiológico sobre una población del centro de España. Actas Dermosifiliogr 1999; 90:295-299.

Mignogna MD, Muzio LI, Favia G, et al. Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. lnt J Dermatol 1998; 37:575-578.

https://doi.org/10.1046/j.1365-4362.1998.00510.x

Carson CW, Conn DL, Czaja AJ, et al. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993; 20:304-309.

Kanazawa K, Yaoita H, Murata K, et al. Association of prurigo with hepatitis C virus infection. Arch Dermatol 1995; 131:852-853.

https://doi.org/10.1001/archderm.1995.01690190108029

Cribier B, Santinelli S, Smith C, et al. Should patients with pruritus be tested for hepatitis C virus infection? A case-controlled study. Brit J Dermatol 2000; 142:1249- 1250.

https://doi.org/10.1046/j.1365-2133.2000.03567.x

Darouti ME, Ela ME. Necrolytic acral erythema: a cutaneous marker of viral hepatitis C. Int J Dermatol 1996; 35:252-256.

https://doi.org/10.1111/j.1365-4362.1996.tb02997.x

Kanazawa K, Yaoita H, Tsuda F. Hepatitis C virus infection in patients with urticaria. J Acad Amer Dermatol 1996; 35:195-198.

https://doi.org/10.1016/S0190-9622(96)90322-9

Reichel M, Mauro TM. Urticaria and hepatitis C. Lancet 1990; 336:822-823.

https://doi.org/10.1016/0140-6736(90)93296-2

Cribier BJ, Santinelli F, Schmitt C, et al. Chronic urticaria is non significantly associated with hepatitis C or hepatitis G. Arch Dermatol 1999; 135:1335-1339.

https://doi.org/10.1001/archderm.135.11.1335

García RG, Pérez JL. Manifestaciones dermatológicas en los pacientes con hepatitis C. Piel 2002; 17:51-56.

https://doi.org/10.1016/S0213-9251(02)72537-9

Dumas V, Thieulent N, Sovillet AL, et al. Recurrent erythema multiforme and chronic hepatitis C: efficacy of interferon alpha. Brit J Dermatol 2000; 142:1248- 1249.

https://doi.org/10.1046/j.1365-2133.2000.03566.x

Ural I, Erel A, Ozenirler S, et al. Nodular vasculitis associated with chronic hepatitis C. J Eur Acad Dermatol Venereol 2002; 16:298-299.

https://doi.org/10.1046/j.1468-3083.2002.00487_11.x

Hadziyannis SJ. Skin diseases associated with hepatitis C virus infection. J Eur Acad Venereol 1998; 10:12-21.

https://doi.org/10.1111/j.1468-3083.1998.tb00922.x

Neri S, Racih C, D'Angelo G, et al. Hyde's prurigo nodularis and chronic HCV hepatitis. J Hepatol 1998; 28:161-164.

https://doi.org/10.1016/S0168-8278(98)80216-X

Podanyi B, Lengyel G, Harsing J, et al. Skin diseases associated with chronic hepatitis C. Orv Hetil 1998; 139:2633-2637.

Jackson JM, Callen JP. Scarring alopecia and sclerodermatous changes of the scalp in a patient with hepatitis C infection. J Am Acad Dermatol 1998; 39:824-826.

https://doi.org/10.1016/S0190-9622(98)70357-3

Cómo citar
1.
Hormaza X. Infección por hepatitis C: Enfoque para dermatólogos. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de junio de 2003 [citado 27 de septiembre de 2022];11(2):145-54. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/753

Descargas

La descarga de datos todavía no está disponible.
Publicado
2003-06-01
Sección
Revisión de tema